登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，4月19日，（第2版更新）No Evidence for Temperature-Dependence of the COVID-19 Epidemic》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-04-21

  • No Evidence for Temperature-Dependence of the COVID-19 Epidemic

    View ORCID ProfileTahira Jamil, View ORCID ProfileIntikhab Syed Alam, View ORCID ProfileTakashi Gojobori, View ORCID ProfileCarlos Duarte

    doi: https://doi.org/10.1101/2020.03.29.20046706

    Abstract

    The pandemic of the COVID-19 disease extended from China across the north-temperate zone, and more recently to the tropics and southern hemisphere. We find no evidence that spread rates decline with temperatures above 20 oC, suggesting that the COVID-19 disease is unlikely to behave as a seasonal respiratory virus.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.03.29.20046706v2
83浏览量
原文链接
相关报告

  • 《MedRxiv，4月20日，（第2版更新）Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-21
    • Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence Krishna Sriram, Paul A. Insel doi: https://doi.org/10.1101/2020.03.25.20043927 Abstract Background: Concerns have been raised regarding the safety of Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in patients with COVID-19, based on the hypothesis that such medications may raise expression of ACE2, the receptor for SARS-CoV-2. Methods: We conducted a literature review of studies (n=12) in experimental animals and human subjects (n=11) and evaluated the evidence regarding the impact of administration of ACEIs and ARBs on ACE2 expression. We prioritized studies that assessed ACE2 protein expression data, measured directly or inferred from ACE2 activity assays. Results: The findings in animals are inconsistent with respect to an increase in ACE2 expression in response to treatment with ACEIs or ARBs. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    95浏览量
    原文链接

  • 《MedRxiv，4月20日，（第2版更新）Links between air pollution and COVID-19 in England》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-21
    • Links between air pollution and COVID-19 in England View ORCID ProfileMarco Travaglio, View ORCID ProfileRebeka Popovic, View ORCID ProfileYizhou Yu, View ORCID ProfileNuno Leal, View ORCID ProfileL. Miguel Martins doi: https://doi.org/10.1101/2020.04.16.20067405 Abstract In December 2019 a novel disease [coronavirus disease 19 (COVID-19) emerged in the Wuhan province of the People's Republic of China. COVID-19 is caused by a novel coronavirus (SARS-CoV-2) thought to have jumped species, from another mammal to humans. A pandemic caused by this virus is running rampant throughout the world. Thousands of cases of COVID-19 are reported in England and over 10,000 patients have died. Whilst there has been progress in managing this disease, it is not clear which factors, besides age, affect the severity and mortality of COVID-19. A recent analysis of COVID-19 in Italy identified links between air pollution and death rates. Here, we explored the correlation between three major air pollutants linked to fossil fuels and SARS-CoV-2 lethality in England. We compare up-to-date, real-time SARS-CoV-2 cases and death measurements from public databases to air pollution data monitored across over 120 sites in different regions. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    125浏览量
    原文链接